4-161587568-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_020116.5(FSTL5):c.902G>A(p.Gly301Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000276 in 1,594,742 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000039 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000026 ( 0 hom. )
Consequence
FSTL5
NM_020116.5 missense
NM_020116.5 missense
Scores
6
11
2
Clinical Significance
Conservation
PhyloP100: 7.57
Genes affected
FSTL5 (HGNC:21386): (follistatin like 5) Predicted to enable calcium ion binding activity. Predicted to be involved in cell differentiation. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FSTL5 | NM_020116.5 | c.902G>A | p.Gly301Glu | missense_variant | 8/16 | ENST00000306100.10 | NP_064501.2 | |
FSTL5 | NM_001128427.3 | c.899G>A | p.Gly300Glu | missense_variant | 8/16 | NP_001121899.1 | ||
FSTL5 | NM_001128428.3 | c.899G>A | p.Gly300Glu | missense_variant | 8/15 | NP_001121900.1 | ||
FSTL5 | XM_011532126.1 | c.902G>A | p.Gly301Glu | missense_variant | 8/15 | XP_011530428.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FSTL5 | ENST00000306100.10 | c.902G>A | p.Gly301Glu | missense_variant | 8/16 | 1 | NM_020116.5 | ENSP00000305334 | P5 | |
FSTL5 | ENST00000379164.8 | c.899G>A | p.Gly300Glu | missense_variant | 8/16 | 1 | ENSP00000368462 | A1 | ||
FSTL5 | ENST00000427802.2 | c.899G>A | p.Gly300Glu | missense_variant | 8/15 | 1 | ENSP00000389270 | A1 | ||
FSTL5 | ENST00000511170.1 | n.264G>A | non_coding_transcript_exon_variant | 3/5 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151984Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
6
AN:
151984
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000151 AC: 36AN: 237778Hom.: 0 AF XY: 0.0000856 AC XY: 11AN XY: 128518
GnomAD3 exomes
AF:
AC:
36
AN:
237778
Hom.:
AF XY:
AC XY:
11
AN XY:
128518
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000263 AC: 38AN: 1442640Hom.: 0 Cov.: 27 AF XY: 0.0000167 AC XY: 12AN XY: 717184
GnomAD4 exome
AF:
AC:
38
AN:
1442640
Hom.:
Cov.:
27
AF XY:
AC XY:
12
AN XY:
717184
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152102Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74334
GnomAD4 genome
AF:
AC:
6
AN:
152102
Hom.:
Cov.:
33
AF XY:
AC XY:
5
AN XY:
74334
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
17
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2022 | The c.902G>A (p.G301E) alteration is located in exon 8 (coding exon 7) of the FSTL5 gene. This alteration results from a G to A substitution at nucleotide position 902, causing the glycine (G) at amino acid position 301 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Uncertain
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;.;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;D
REVEL
Pathogenic
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
P;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at